Cannabis and Linden Tree Extracts Together Showed Powerful Neuroprotective Synergy

Combining cannabis and Tilia (linden) extracts produced synergistic neuroprotection that fully restored cell viability against glutamate toxicity and shifted brain immune cells toward an anti-inflammatory state.

Saint Martin, Elina Malen et al.·Planta medica·2026·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-08597Animal StudyPreliminary Evidence2026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Cannabis extract alone partially reversed glutamate-induced cell death (52-200% recovery). The linden tree extract also showed partial protection (22-82%). Combined, they produced synergistic effects: 133-284% recovery, fully restoring cell viability to control levels. The combination also reduced reactive oxygen species (52-58%) and most dramatically shifted microglia from inflammatory to anti-inflammatory phenotypes.

Key Numbers

Cannabis alone: 52-200% viability recovery. Linden alone: 22-82%. Combined: 133-284% (full restoration). ROS reduction: 52-58%. Shifted microglia from pro-inflammatory phenotype 1 to anti-inflammatory phenotype 2.

How They Did This

In vitro study using HT-22 hippocampal neurons (glutamate toxicity model) and primary rat microglia (LPS inflammation model). Cell viability by MTT, ROS by fluorescence, microglial phenotypes by immunofluorescence.

Why This Research Matters

The synergistic effect means the combination works better than either extract alone, even at lower individual doses. This supports the concept of multi-botanical approaches for neuroinflammation and could inform formulation of botanical medicines.

The Bigger Picture

Both cannabis and linden have traditional uses for neurological conditions. Demonstrating molecular synergy between them provides scientific support for combination botanical therapies and the broader concept of phytomedicine.

What This Study Doesn't Tell Us

In vitro cell culture only. The specific bioactive compounds responsible for the synergy are not identified. Extract composition varies by preparation method. Translation to in vivo brain effects is uncertain.

Questions This Raises

  • ?Which specific compounds in each extract drive the synergy?
  • ?Could this combination be effective in animal models of epilepsy or neurodegeneration?

Trust & Context

Key Stat:
Combined extracts: full neuroprotection vs partial alone
Evidence Grade:
In vitro study only, demonstrating molecular synergy but far from clinical application.
Study Age:
2026 study.
Original Title:
Synergistic Neuroprotection by Cannabis sativa and Tilia × viridis: Attenuation of Hippocampal Neurons Glutamate-Induced Oxidative Stress and LPS-Driven Microglial Inflammation.
Published In:
Planta medica (2026)
Database ID:
RTHC-08597

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What is synergy in this context?

The combined effect of cannabis and linden extracts was greater than adding their individual effects together, producing full neuroprotection where each alone only provided partial protection.

Could this combination treat neurological conditions?

The cell culture results are promising but very preliminary. Animal and human studies would be needed to determine whether this synergy translates to actual neuroprotection in the brain.

Read More on RethinkTHC

Cite This Study

RTHC-08597·https://rethinkthc.com/research/RTHC-08597

APA

Saint Martin, Elina Malen; Barreiro-Arcos, María Laura; Gomez, María Belén; Soldavini, Giuliana Colonna; Marrassini, Carla; Cogoi, Laura; Peralta, Ignacio; Reinés, Analía; Alonso, María Rosario; Anesini, Claudia. (2026). Synergistic Neuroprotection by Cannabis sativa and Tilia × viridis: Attenuation of Hippocampal Neurons Glutamate-Induced Oxidative Stress and LPS-Driven Microglial Inflammation.. Planta medica. https://doi.org/10.1055/a-2751-0171

MLA

Saint Martin, Elina Malen, et al. "Synergistic Neuroprotection by Cannabis sativa and Tilia × viridis: Attenuation of Hippocampal Neurons Glutamate-Induced Oxidative Stress and LPS-Driven Microglial Inflammation.." Planta medica, 2026. https://doi.org/10.1055/a-2751-0171

RethinkTHC

RethinkTHC Research Database. "Synergistic Neuroprotection by Cannabis sativa and Tilia × v..." RTHC-08597. Retrieved from https://rethinkthc.com/research/saint-2026-synergistic-neuroprotection-by-cannabis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.